Skip to Main content Skip to Navigation
Journal articles

Oncotarget 4790 PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma

Abstract : Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults and one of the most aggressive cancers. PARP-1 is a nuclear protein involved in multiple facets of DNA repair and transcriptional regulation. In this study we dissected the action of PARP inhibition in different GBM cell lines with either functional or mutated PTEN that confers resistance to diverse therapies. In PTEN mutant cells, PARP inhibition induced a severe genomic instability, exacerbated homologous recombination repair (HR) deficiency and down-regulated the Spindle Assembly Checkpoint (SAC) factor BUBR1, leading to mitotic catastrophe (MC). EGFR gene amplification also represents a signature of genetic abnormality in GBM. To more effectively target GBM cells, co-treatment with a PARP inhibitor and an EGFR blocker, erlotinib, resulted in a strong suppression of ERK1/2 activation and in vivo the combined effect elicited a robust reduction in tumour development. In conclusion, PARP inhibition targets PTEN-deficient GBM cells through accentuation of SAC repression and aggravation of HR deficiency, leading to the induction of genomic instability and eventually deriving to mitotic catastrophe (MC); the inhibition of PARP and co-treatment with an inhibitor of pro-survival pathways strongly retarded in vivo gliomagenesis.
Document type :
Journal articles
Complete list of metadatas

Cited literature [40 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01137430
Contributor : Mireille Bos <>
Submitted on : Monday, March 30, 2015 - 4:04:59 PM
Last modification on : Thursday, April 9, 2020 - 11:52:22 AM
Long-term archiving on: : Tuesday, April 18, 2017 - 4:58:22 AM

File

2993-36835-2-PB.pdf
Publisher files allowed on an open archive

Identifiers

  • HAL Id : inserm-01137430, version 1
  • PUBMED : 25576921

Collections

Citation

Jara Majuelos-Melguizo, María Isabel Rodríguez, Laura López-Jiménez, Jose Rodríguez-Vargas, Juan Martí Martín-Consuegra, et al.. Oncotarget 4790 PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma. Oncotarget, Impact journals, 2014, pp.4790-4803. ⟨inserm-01137430⟩

Share

Metrics

Record views

861

Files downloads

402